Sun Pharma shares slip over 6% after Q1 earnings
Updated : August 14, 2019 10:34 AM IST
Shares of Sun Pharmaceutical Industries slipped over 6 percent on Wednesday despite strong earnings for the June 2019 quarter
R&D expenses were 5.1 percent of revenues as against 7 percent of revenues in the June quarter last year.
The company's sales in the US rose 12 percent YoY on the back of increased spending on branding and promotion in the country.
Have you signed up for Primo, our daily newsletter?It has all the stories and data on the market, business, economy and tech that you need to know.
THANK YOU! You made our day. See you every morningYOUR EMAIL IS ON ITS WAY. Check your inbox for future updates.
To keep watching CNBC-TV18, India's No. 1 English Business News Channel, call your Cable or DTH Operator and subscribe now for just Rs. 4 per month. You can also subscribe to CNBC-TV18 Prime HD for Re 1/- per month.Find out more